Adaptimmune Therapeutics
ADAP
#8469
Rank
โ‚น13.02 B
Marketcap
โ‚น50.91
Share price
1.35%
Change (1 day)
36.23%
Change (1 year)

EPS for Adaptimmune Therapeutics (ADAP)

EPS in 2023 (TTM): -โ‚น43.78

According to Adaptimmune Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น45.33. In 2022 the company made an earnings per share (EPS) of -โ‚น86.63 a decrease over its 2021 EPS that were of -โ‚น86.63.

EPS history for Adaptimmune Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น43.78-49.46%
2022-โ‚น86.63-0%
2021-โ‚น86.636.25%
2020-โ‚น81.54-27.27%
2019-โ‚น112.1129.41%
2018-โ‚น86.6320.09%
2017-โ‚น72.14-16.73%
2016-โ‚น86.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น610.66 1,247.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น79.84 76.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น334.63 638.20%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚น24.06-153.08%๐Ÿ‡บ๐Ÿ‡ธ USA